5 Pharma Companies Making Treatment for Opioid Overdose

4. Teva Pharmaceutical Industries Limited (NYSE: TEVA)

Number of Hedge Fund Holders: 24    

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a pharmaceutical company based in Israel. It is placed fourth on our list of 10 pharma companies making treatment for opioid overdose. In earnings results for the second quarter, posted on July 28, the firm reported earnings per share of $0.59, in line with estimates. The revenue over the period was close to $4 billion, up close to 1% year-on-year. In 2019, while settling an opioid-related case, the firm offered to provide $23 billion worth of opioid addiction treatment drugs. 

On April 6, investment advisory RBC Capital maintained a Sector Perform rating on Teva Pharmaceutical Industries Limited (NYSE: TEVA) stock with a price target of $11. Daniel Busby, an analyst at the firm, issued the ratings update. 

Out of the hedge funds being tracked by Insider Monkey, Nebraska-based investment firm Berkshire Hathaway is a leading shareholder in Teva Pharmaceutical Industries Limited (NYSE: TEVA) with 42 million shares worth more than $493 million.